Tetracycline resistance in Chilean clinical isolates of Helicobacter pylori

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 3, 2009, Pages 470-473

  Toledo, Héctor ^a   López Solís, Remigio ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

16S rRNA gene; Nucleotide substitutions; PCR RFLP

Indexed keywords

RNA 16S; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BASE PAIRING; CHILE; CONCENTRATION RESPONSE; DNA SEQUENCE; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ANTI-BACTERIAL AGENTS; CHILE; DNA, BACTERIAL; DNA, RIBOSOMAL; GENES, RRNA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; REAGENT KITS, DIAGNOSTIC; RNA, RIBOSOMAL, 16S; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TETRACYCLINE RESISTANCE;

EID: 77950302262     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp457     Document Type: Article

References (22)

1. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev 1997; 10: 720-41.
2. Kuipers EJ. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1997; 11 Suppl 1: 71-88.
3. Romano M, Iovene MR, Russo MI et al. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. J Clin Pathol 2008; 61: 1112-5.
4. Wueppenhorst N, Stueger H-P, Kist M et al. Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany. J Antimicrob Chemother 2009; 63: 648-53.
5. Megraud F, Marshall BJ. How to treat Helicobacter pylori. First-line, second-line, and future therapies. Gastroenterol Clin North Am 2000; 29: 759-73.
6. Gisbert JP, Pajares JM. Helicobacter pylori therapy: first-line options and rescue regimen. Dig Dis 2001; 19: 134-43.
7. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 2001; 65: 232-60.
8. Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007; 20: 280-322.
9. Gerrits MM, van Vliet AHM, Kuipers EJ et al. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis 2006; 6: 699-709.
10. Vallejos C, Garrido L, Cáceres D et al. Prevalence of metronidazole, claritromycin and tetracycline resistance in Helicobacter pylori isolated from Chilean patients. Rev Med Chile 2007; 135: 287-93.
11. Gerrits MM, de Zoete MR, Arents NL et al. 16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother 2002; 46: 2996-3000.
12. Ribeiro ML, Gerrits MM, Benvengo YHB. Detection of high-level resistance in clinical isolates of Helicobacter pylori using PCR-RFLP. FEMS Immunol Med Microbiol 2004; 40: 57-61.
13. Garrido L, Toledo H. Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene. Helicobacter 2007; 12: 505-9.
14. Tomb JF, White O, Kerlavage AR et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997; 388: 539-47.
15. Silva FM, Eisig JN, Chehter EZ et al. Omeprazole, furazolidone, and tetracycline: an eradication treatment for resistant Helicobacter pylori in Brazilian patients with peptic ulcer disease. Rev Hosp Clin Fac Med Sao Paulo 2002; 57: 205-8.
16. Dailidiene D, Bertoli MT, Miciuleviciene J et al. Emergence of tetracycline resistance in Helicobacter pylori: multiple mutational changes in 16S ribosomal DNA and other genetic loci. Antimicrob Agents Chemother 2002; 46: 3940-6.
17. Mendonça S, Ecclissato C, Sartori MS et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 2000; 5: 79-83.
18. Glupczynski Y, Broutet N, Cantagrel A et al. Comparison of the E test and agar dilution method for antimicrobial susceptibility testing of Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2002; 21: 549-52.
19. Gerrits MM, Berning M, van Vliet AHM et al. Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother 2003; 47: 2984-6.
20. Khan R, Nahar S, Mukhopadhyay AK et al. Isolation of tetracycline-resistant clinical Helicobacter pylori without mutations in 16S rRNA gene in Bangladesh. Microbiol Immunol 2008; 52: 508-11.
21. Wu JY, Kim JJ, Reddy R et al. Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob Agents Chemother 2005; 49: 578-83.
22. Anoushiravani M, Falsafi T, Niknam V. Proton-motive force dependent efflux of tetracycline in clinical isolates of Helicobacter pylori. J Med Microbiol 2009; 58: 1309-13.